Hinge Health, INC Schedule 13G passive stakes

Insight Venture Partners entities have filed an amendment to their Schedule 13G, reporting changes in their beneficial ownership of Hinge Health, Inc. Class A Common Stock.

11.2 Capital entities and Qian Zhuang have collectively reported beneficial ownership of 2,464,657 shares of Hinge Health's Class A Common Stock, representing 4.0% of the outstanding shares.

Atomico Advisors IV, Ltd. and its affiliates have reported beneficial ownership of 2,300,000 shares of Hinge Health, Inc. Class A Common Stock, representing 2.88% of the class.

Hansa Invest, a German investment management company, has disclosed beneficial ownership of 1,476,600 ordinary shares in Hinge Health, Inc., representing 2.7% of the class.

The Vanguard Group filed an amended Schedule 13G, reporting 0% beneficial ownership in Hinge Health Inc. following an internal realignment.

Daniel Antonio Perez, a U.S. citizen, reported beneficial ownership of 15.7% of Hinge Health, Inc.'s Class A Common Stock as of December 31, 2025.

Alkeon Capital Management LLC and its founder, Panayotis D. Sparaggis, have disclosed a 2.1% beneficial ownership stake in Hinge Health, Inc. Class A Common Stock.

Insight Partners and its affiliated entities have disclosed a significant 19.8% beneficial ownership stake in Hinge Health, Inc.'s Class A Common Stock.

Qian Zhuang and affiliated 11.2 Capital entities disclosed beneficial ownership of 9.8% of Hinge Health, Inc.'s Class A Common Stock as of December 31, 2025.

Jane Street Group, LLC and its affiliates reported a 4.2% beneficial ownership stake in Hinge Health, Inc.'s Class A Common Stock as of December 31, 2025.

The Vanguard Group reported a 6.87% beneficial ownership stake in Hinge Health Inc. common stock as of December 31, 2025.

HANSAINVEST Hanseatische Investment-Limited Co has reported a 5.69% beneficial ownership stake in Hinge Health, Inc. as of December 31, 2025.

Jane Street Group, LLC and its affiliates have reported a beneficial ownership of 5.6% in Hinge Health, Inc.'s Class A Common Stock.

Alyeska Investment Group, L.P. and its affiliates reported beneficial ownership of 4.75% of Hinge Health, Inc.'s Class A Common Stock as of September 30, 2025.

Alyeska Investment Group, L.P. and its affiliates have disclosed a beneficial ownership of 5.51% in Hinge Health, Inc.'s Class A Common Stock.

Coatue Management and its affiliates report a significant beneficial ownership stake of 9.9% in Hinge Health, Inc.'s Class A Common Stock.

Insight Entities, including Insight Venture Partners funds, have disclosed a collective beneficial ownership of 28.8% in Hinge Health, Inc.'s Class A Common Stock.

Bessemer Venture Partners and affiliated entities have disclosed a significant beneficial ownership stake in Hinge Health, Inc., totaling 13.1% of Class A Common Stock.

11.2 Capital entities and Qian Zhuang have disclosed significant beneficial ownership in Hinge Health, Inc.'s Class A Common Stock.

Gabriel M.I. Mecklenburg, a key insider at Hinge Health, Inc., reported beneficial ownership of 13.0% of the company's Class A Common Stock as of June 30, 2025.

Daniel Antonio Perez, co-founder of Hinge Health, Inc., has reported beneficial ownership of 28.2% of the company's Class A Common Stock as of June 30, 2025.

Alkeon Capital Management LLC and Panayotis D. Sparaggis have disclosed a 5.7% beneficial ownership stake in Hinge Health, Inc.'s Class A Common Stock.

Atomico Advisors IV, Ltd. and its affiliated funds, Atomico IV, L.P. and Atomico IV (Guernsey), L.P., have disclosed a combined 8.3% beneficial ownership stake in Hinge Health, Inc. following the company's initial public offering.